Hansa Biopharma’s Idefrix leads to one-year GvHD survival in kidney transplant Clinical Trials Arena 20:32 Thu, 28 May
Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation PR Newswire (Press Release) 07:30 Wed, 27 May
Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026 PR Newswire (Press Release) 03:56 Tue, 26 May
Wedbush Reaffirms Outperform On Hansa Biopharma After ?115M Serb Licensing Deal RTT News 15:45 Wed, 20 May
EMA recommends approvals for both oral and high-dose pen of Wegovy Pharmaceutical Technology 17:03 Tue, 26 May Novo Nordisk Ozempic Pharma All sources
Hansa Biopharma’s Idefrix leads to one-year GvHD survival in kidney transplant Clinical Trials Arena 20:32 Thu, 28 May Hansa Biopharma
The 2026 MedTech Forum: innovation and regulation lead the agenda Verdict Medical Devices 8d Sweden Northern Europe
EMA recommends next season's Covid vaccines should target Xfg variant Rock Hill Herald 8d Coronavirus Vaccine Article paywall
NATO fighters intercept six Russian military aircraft over the Baltic in a single day Euromaidan Press 1d Russia NATO Lithuania
